Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus for neurotoxicity in liver transplant recipients
NCT03823768Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2020
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in neurotoxicity (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Change in Neurotoxicity Burden at 6 months. Started Jan 2020; status: completed.
02
Drugs
tacrolimus
03
Conditions
neurotoxicity
Beyond the preview
Go deeper on NCT03823768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03823768.